Supernus Pharmaceuticals reported $-1523000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US USD 1.33B 442M
Ani Pharmaceuticals ANIP:US USD -4995000 7.92M
Aurora Cannabis Inc ACB:CN CAD -54500000 570.08M
Bristol Myers Squibb BMY:US USD 1.94B 528M
Canopy Growth Corp WEED:CN CAD -159665000 1.7B
Cara Therapeutics CARA:US USD -23845000 19.37M
Corcept Therapeutics CORT:US USD 31.93M 502K
Eli Lilly And LLY:US USD 1.84B 159.9M
Endo International Ordinary Shares ENDP:US USD -636822000 1.1B
Horizon Pharma HZNP:US USD 160.61M 72.05M
Marinus Pharmaceuticals MRNS:US USD -30099000 6.67M
Pacira Pharmaceuticals PCRX:US USD 21.29M 9.95M
Perrigo Ordinary Shares PRGO:US USD 33.5M 49.7M
Pfizer PFE:US USD 5.17B 4.24B
Revance Therapeutics RVNC:US USD -77484000 19.64M
Supernus Pharmaceuticals SUPN:US USD -1523000 12.87M
Teva Pharmaceutical Industries TEVA:US USD 419M 1.37B
United Therapeutics UTHR:US USD 314.3M 112.5M
Xeris Pharmaceuticals Inc XERS:US USD -18780000 136K